Sangrix Inc. (SGRX) stock
SGRXNasdaqFinance ServicesFiscal year ends June 30
$2.56−0.21 (-7.58%)
Close on Nov 17, 2026Market cap $1.91MP/E –Yield –
Sangrix r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Sangrix
Sangrix has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?